Varian Medical Systems (NYSE: VAR) and Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership.

Analyst Ratings

This is a summary of current ratings and recommmendations for Varian Medical Systems and Invivo Therapeutics Holdings Corp, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Varian Medical Systems 2 6 2 0 2.00
Invivo Therapeutics Holdings Corp 0 1 0 0 2.00

Varian Medical Systems presently has a consensus price target of $94.94, indicating a potential downside of 5.92%. Invivo Therapeutics Holdings Corp has a consensus price target of $6.00, indicating a potential upside of 293.44%. Given Invivo Therapeutics Holdings Corp’s higher possible upside, analysts plainly believe Invivo Therapeutics Holdings Corp is more favorable than Varian Medical Systems.

Profitability

This table compares Varian Medical Systems and Invivo Therapeutics Holdings Corp’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Varian Medical Systems 9.50% 24.70% 11.12%
Invivo Therapeutics Holdings Corp N/A -118.45% -96.82%

Earnings and Valuation

This table compares Varian Medical Systems and Invivo Therapeutics Holdings Corp’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Varian Medical Systems $3.27 billion 2.83 $643.00 million $3.04 33.19
Invivo Therapeutics Holdings Corp N/A N/A -$25.77 million N/A N/A

Varian Medical Systems has higher revenue and earnings than Invivo Therapeutics Holdings Corp.

Insider & Institutional Ownership

99.3% of Varian Medical Systems shares are held by institutional investors. 0.9% of Varian Medical Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Varian Medical Systems beats Invivo Therapeutics Holdings Corp on 8 of the 9 factors compared between the two stocks.

About Varian Medical Systems

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.

About Invivo Therapeutics Holdings Corp

InVivo Therapeutics Holdings Corp., formerly Design Source, Inc., is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company’s approach to treating acute SCIs is based on its investigational Neuro Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion and is intended to treat acute spinal cord injury. The Neuro-Spinal Scaffold consists of biocompatible and bioresorbable polymers, which include poly lactic-co-glycolic acid (PLGA) and Poly-L-Lysine (PLL). The Company is also evaluating other technologies and therapeutics that may be complementary to its development of the Neuro-Spinal Scaffold implant. The Company has a clinical development program for acute SCI and a preclinical development program for chronic SCI.

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.